Indications and uses
Uses * helps prevent sunburn * higher SPF gives more sunburn protection
AHAVA ACTIVE DEADSEA MINERALS
- Manufacturer
- AHAVA - Dead Sea Laboratories Ltd.
- Effective date
- 2012-02-22
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:30:59
Label at a glance#
ProductAHAVA ACTIVE DEADSEA MINERALS Mineral Suncare spf 30
Active ingredientOCTOCRYLENE, ENSULIZOLE, OCTISALATE, AVOBENZONE, TITANIUM DIOXIDE
Label structure9 sections
Dosage and administration
Directions * shake before using * apply liberally 30 minutes before sun exposure and as needed * children under 6 months of age: ask a doctor
Contacts and useful links#
Websitewww.ahava.com
www.ahava.com
www.ahava.comLabel contents#
Full prescribing information#
Active Ingredient Section
Drug Facts
Active Ingredients Avobenzone (3%) Ensulizole (1%) Octisalate (2%) Octocrylene (10%) Titanium Dioxide (1.52%)
Purpose Section
Purpose Sunscreen
Keep Out of reach of Children Section
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Uses Section
Uses
* helps prevent sunburn
* higher SPF gives more sunburn protection
Warnings Section
Warnings
For External Use Only When using this product keep out of eyes. Rinse with water to remove
Stop use and ask a doctor if rash or irritation develops and lasts If swallowed, get medical help or contact a Poison Control Center right away.
Directions Section
Directions
* shake before using
* apply liberally 30 minutes before sun exposure and as needed
* children under 6 months of age: ask a doctor
Inactive Ingredient Section
Inactive ingredients: Aqua (Water), C12-15 Alkyl Benzoate, Cyclomethicone, Propanediol, Methylene Bis-Benzotriazolyl Tetramethtbutylphenol, Trimethoxycaprlylsilane, Sodium Hydroxide, Caprylic/Capric Triglyceride, Phenyl Trimethicone, Tricontanyl PVP, Phenoxyethanol, 1,2-Hexandiol, Caprylyl Glycol, Cetearyl Alcohol, Parfum (Fragrance), Tocopheryl (Vitamin E) Acetate, Ethylhexylglycerin, Aloe Barbadensis Leaf Extract, Panthenol (Pro-Vitamin B5), Disodium EDTA, Acrylates/ C10-30 Alkyl Acrylate Crosspolymer, Xanthan Gum, Allantoin, Polyglyceryl-10 Pentastearate, Behenyl Alcohol, Sodium Stearoyl Lactylate, Potassium Cetyl Phosphate, Dunalietta Salina (Dead Sea Alga) Extract, Maris Sal (Dead Sea Water)
The Osmotertm Dead Sea Water
Major Elements /in mg/L: Micro Elements /in ppml:
Magnesium Mg 92,000 Stronium Sr 670
Calcium Ca 35,000 Boron B 120
Bromine Br 14,000 Lithium Li 40
Sodium Na 2,700 Manganese Mn 10
Potassium K 2,100 Barium Ba 9
Other information Section
Other information
* provides moderate protection against sunburn
Package Label
The AHAVA Osmoter tm A gift from nature, Dead Sea minerals are known to improve your skin's well-being and youthfulness.
The osmoter tm is a unique blend of minerals contained in all AHAVA products. It optimizes cell metabolism, strenghtens skin against UV damage, and significantly increases moisture to keep your skin looking young and supple.
AHAVA ACTIVE DEAD SEA MINERALS SPRAY spf 30 mineral SUNCARE
Sun Protection Anti-Aging Moisturizing Spray
* moderate UVA/UVB sunscreen
* very water resistant
suitable for children
250 ml / 8.5 fl. oz
Sun protection Anti-Aging moisturizing Spray SPF 30 enriched with Mineral Skin Osmoter tm
Protect your skin from the damages of the sun with this quality blend (Multi-Layer Protection System tm) of highly effective sunscreens. Dead Sea minerals and seaweed, essential vitamins and moisturizing agents, all proven to be efficient in fighting premature aging. An easy-to-apply light milk.
* Mineral Skin Osmoter tm - Ahava unique blend of Dead Sea minerals proven to reduce the damage of sun radiation.
Suitable for children. Approved for sensitive skin. Allergy tested. Mineral oil free. Paraben free. Absorbs more than 90% of UVA rays (according to the Australian standards). Retains SPF after 80 minutes of activity in the water.
Ahava advice: Avoid exposing children under 6 months of age to the sun. The use of a high sun protection factor for children is recommended (SPF 30 and up). Avoid extended exposure to the sun, even while using this product.
www.ahava.com
Against animal testing PARABEN FREE ALLERGY TESTED
A product of AHAVA Dead Sea Laboratories, Ltd. Dead Sea, israel. Manufactures by Zohar Cosmetics Ltd. POB 16 Yerucham, israel.
In USA: Ahava NA, 411 5th Ave. NY, 10016 1-800-366-7254
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60289-030-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1b09-f424-e053-dadaa90a57ce | 86f0e36e-e824-483a-9a53-3b20cf109844 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60289-030-30 | AHAVA ACTIVE DEADSEA MINERALSMineral Suncare spf 30 | 250 mL in 1 BOTTLE, SPRAY | SPRAY | 250 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| ENSULIZOLE | ACTIVE INGREDIENT | 9YQ9DI1W42 | 1 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| ENSULIZOLE | ACTIVE MOIETY | 9YQ9DI1W42 | 1 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| 1,2-HEXANEDIOL | INACTIVE INGREDIENT | TR046Y3K1G | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| ALLANTOIN | INACTIVE INGREDIENT | 344S277G0Z | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| ALPHA-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| BARIUM | INACTIVE INGREDIENT | 24GP945V5T | 1 | |
| BISOCTRIZOLE | INACTIVE INGREDIENT | 8NT850T0YS | 1 | |
| BORON | INACTIVE INGREDIENT | N9E3X5056Q | 1 | |
| BROMINE | INACTIVE INGREDIENT | SBV4XY874G | 1 | |
| CALCIUM | INACTIVE INGREDIENT | SY7Q814VUP | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CARBOMER INTERPOLYMER TYPE A (55000 MPA.S) | INACTIVE INGREDIENT | 59TL3WG5CO | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| CYCLOMETHICONE | INACTIVE INGREDIENT | NMQ347994Z | 1 | |
| DOCOSANOL | INACTIVE INGREDIENT | 9G1OE216XY | 1 | |
| DUNALIELLA SALINA | INACTIVE INGREDIENT | F4O1DKI9A6 | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| ETHYLHEXYLGLYCERIN | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| LITHIUM | INACTIVE INGREDIENT | 9FN79X2M3F | 1 | |
| MAGNESIUM | INACTIVE INGREDIENT | I38ZP9992A | 1 | |
| MANGANESE | INACTIVE INGREDIENT | 42Z2K6ZL8P | 1 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| PANTHENOL | INACTIVE INGREDIENT | WV9CM0O67Z | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| PHENYL TRIMETHICONE | INACTIVE INGREDIENT | DR0K5NOJ4R | 1 | |
| POLYGLYCERYL-10 OLEATE | INACTIVE INGREDIENT | 55C81W76DH | 1 | |
| POTASSIUM | INACTIVE INGREDIENT | RWP5GA015D | 1 | |
| POTASSIUM CETYL PHOSPHATE | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| PROPANEDIOL | INACTIVE INGREDIENT | 5965N8W85T | 1 | |
| SODIUM | INACTIVE INGREDIENT | 9NEZ333N27 | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 1 | |
| SODIUM STEAROYL LACTYLATE | INACTIVE INGREDIENT | IN99IT31LN | 1 | |
| STRONTIUM | INACTIVE INGREDIENT | YZS2RPE8LE | 1 | |
| TRIACONTANYL PVP (WP-660) | INACTIVE INGREDIENT | N0SS3Q238D | 1 | |
| TRIMETHOXYCAPRYLYLSILANE | INACTIVE INGREDIENT | FZ07E4LW2M | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- AHAVA ACTIVE DEADSEA MINERALS Mineral Suncare spf 30
- OCTOCRYLENE
- ENSULIZOLE
- OCTISALATE
- AVOBENZONE
- TITANIUM DIOXIDE
- WATER
- ALKYL (C12-15) BENZOATE
- CYCLOMETHICONE
- PROPANEDIOL
- BISOCTRIZOLE
- TRIMETHOXYCAPRYLYLSILANE
- SODIUM HYDROXIDE
- MEDIUM-CHAIN TRIGLYCERIDES
- PHENYL TRIMETHICONE
- TRIACONTANYL PVP (WP-660)
- PHENOXYETHANOL
- 1,2-HEXANEDIOL
- CAPRYLYL GLYCOL
- CETOSTEARYL ALCOHOL
- ALPHA-TOCOPHEROL ACETATE
- ETHYLHEXYLGLYCERIN
- ALOE VERA LEAF
- PANTHENOL
- EDETATE DISODIUM
- CARBOMER INTERPOLYMER TYPE A (55000 MPA.S)
- XANTHAN GUM
- ALLANTOIN
- POLYGLYCERYL-10 OLEATE
- DOCOSANOL
- SODIUM STEAROYL LACTYLATE
- POTASSIUM CETYL PHOSPHATE
- DUNALIELLA SALINA
- MAGNESIUM
- CALCIUM
- BROMINE
- SODIUM
- POTASSIUM
- STRONTIUM
- BORON
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 60289-030 | 60289-030-30 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVITREAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | OINTMENT / TOPICAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LOTION / TOPICAL | 21 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LOTION, AUGMENTED / TOPICAL | ADJ PH | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / TOPICAL | 1428 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / RECTAL | 452 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / PARENTERAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRACAUDAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / PERIODONTAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / AURICULAR (OTIC) | 0.8 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE / ORAL | 60 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | POWDER, FOR SOLUTION / ORAL | ADJ PH | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / INTRAVENOUS | 0.03 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | EMULSION / ORAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | DISC / TOPICAL | ADJ PH | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | INJECTION, EMULSION / INTRAVENOUS | 1.1 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-ARTERIAL | 176 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SUBCONJUNCTIVAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION / ENDOTRACHEAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SPRAY / NASAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / ORAL | 0.5 mg/1ml | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SPRAY / TOPICAL | 540 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | FILM, SOLUBLE / ORAL | 1 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | EMULSION / OPHTHALMIC | 0.02 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | DROPS / OPHTHALMIC | NA | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / PARENTERAL | ADJ PH | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CAPSULE / ORAL | 4771 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRA-ARTICULAR | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET / ORAL | 10 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | SPRAY / TOPICAL | 1 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 6 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | LOZENGE / ORAL | 1264 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / TOPICAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / ORAL | 30 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVENOUS | 10 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRASYNOVIAL | ADJ PH | ||
| DOCOSANOL | DOCOSANOL | 9G1OE216XY | SOLUTION / TOPICAL | 1.1 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-AMNIOTIC | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRACARDIAC | 2 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, COATED / ORAL | 0.08 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / INTRA-ARTICULAR | 1 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | AEROSOL, FOAM / TOPICAL | 0.27 %w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | GEL / TOPICAL | 12 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING / ORAL | 0.15 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.01 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / PERINEURAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAVENOUS | 7 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL / TOPICAL | 70 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | 600 mg | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5793e66f-b21b-45ac-ba77-43d1ddb45acf | 86f0e36e-e824-483a-9a53-3b20cf109844 | 2012-02-22 | Warnings | 5793e66f-b21b-45ac-ba77-43d1ddb45acf 86f0e36e-e824-483a-9a53-3b20cf109844 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.